Tetrodotoxin, a sodium-channel blocking agent, is an indispensable tool in neurophysiological research. The overall objectives of this project are to develop practical procedures for the synthesis of tetrodotoxin derivatives which will then be readily available for research on the nature of the sodium channel and the mechanism of nerve conduction. Fundamentally these derivatives will be tetrodotoxin analogs modified at C-11. They will be designed to serve as photoaffinity, spin, fluorescent, and radioactive labels. These derivatives may also be adapted for the synthesis of compounds to be used in developing an immunoassay for tetrodotoxin and also for derivatives that may serve as local anesthetics. We propose to do this by protecting the 4 and 9 hydroxy groups with anhydro formation. Finally, the 4,9-anhydro bridge will be hydrolyzed, liberating the original tetrodotoxin structure at the guanidine portion of the molecule but now having a stable substituent introduced at C-11. This work will include continued studies on a practical total synthesis of tetrodotoxin and on structure activity relationships.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
2R01NS014345-10A1
Application #
3395490
Study Section
Medicinal Chemistry Study Section (MCHA)
Project Start
1978-06-01
Project End
1990-03-31
Budget Start
1988-04-01
Budget End
1989-03-31
Support Year
10
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Stanford University
Department
Type
Schools of Arts and Sciences
DUNS #
800771545
City
Stanford
State
CA
Country
United States
Zip Code
94305
Koos, M; Mosher, H S (1986) A convenient synthesis of apiose. Carbohydr Res 146:335-41
Mosher, H S (1986) The chemistry of tetrodotoxin. Ann N Y Acad Sci 479:32-43